EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $445,094 | -20.4% | 27,749 | -22.2% | 0.01% | -30.0% |
| Q3 2022 | $559,000 | -42.0% | 35,680 | -22.9% | 0.01% | -37.5% |
| Q2 2022 | $963,000 | -11.5% | 46,249 | -3.6% | 0.02% | +6.7% |
| Q1 2022 | $1,088,000 | +35.2% | 47,990 | +9.0% | 0.02% | +36.4% |
| Q4 2021 | $805,000 | -6.3% | 44,043 | +8.3% | 0.01% | -8.3% |
| Q3 2021 | $859,000 | +10.6% | 40,658 | -4.7% | 0.01% | +9.1% |
| Q2 2021 | $777,000 | -17.4% | 42,670 | +2.4% | 0.01% | -26.7% |
| Q1 2021 | $941,000 | +9.2% | 41,654 | -3.0% | 0.02% | +7.1% |
| Q4 2020 | $862,000 | -23.0% | 42,939 | -6.3% | 0.01% | -36.4% |
| Q3 2020 | $1,120,000 | -0.3% | 45,808 | -3.2% | 0.02% | -4.3% |
| Q2 2020 | $1,123,000 | +18.6% | 47,309 | -14.0% | 0.02% | 0.0% |
| Q1 2020 | $947,000 | +0.4% | 55,009 | +2.8% | 0.02% | +15.0% |
| Q4 2019 | $943,000 | +1.2% | 53,488 | +1.5% | 0.02% | -4.8% |
| Q3 2019 | $932,000 | -21.4% | 52,688 | -5.0% | 0.02% | -19.2% |
| Q2 2019 | $1,185,000 | +5.5% | 55,450 | +17.5% | 0.03% | +4.0% |
| Q1 2019 | $1,123,000 | +9.9% | 47,176 | -9.2% | 0.02% | 0.0% |
| Q4 2018 | $1,022,000 | +371.0% | 51,954 | +414.1% | 0.02% | +400.0% |
| Q2 2018 | $217,000 | +309.4% | 10,105 | +359.5% | 0.01% | +400.0% |
| Q3 2017 | $53,000 | -5.4% | 2,199 | -3.0% | 0.00% | -50.0% |
| Q2 2017 | $56,000 | – | 2,267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |